Evidence map›Paper›PMID 40340515›Full record

ArticleJournal of clinical microbiology2025

Multicenter evaluation of the eQUANT system for use with disk diffusion AST of gram-negative bacteria directly from positive blood cultures.

Sanjucta Dutta, Michael R Jacobs, Caryn E Good, Ayman M Abdelhamed, Yun C Ying, Adrian Hoyos-Urias, Derrick J Sugui, Jacqueline U Anaeto, Eszter Deak, Rachael Valdez and 3 more

Abstract readMulticenter StudyEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sanjucta DuttaDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Michael R JacobsUniversity Hospital Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio, USA.ORCID 0000-0002-4235-7855
Caryn E GoodUniversity Hospital Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio, USA.
Ayman M AbdelhamedUniversity Hospital Cleveland Medical Center and Case Western Reserve University, Cleveland, Ohio, USA.
Yun C YingQuest Diagnostics, Lewisville, Texas, USA.
Adrian Hoyos-UriasAvails Medical, Inc., Menlo Park, California, USA.
Derrick J SuguiAvails Medical, Inc., Menlo Park, California, USA.
Jacqueline U AnaetoAvails Medical, Inc., Menlo Park, California, USA.
Eszter DeakAvails Medical, Inc., Menlo Park, California, USA.
Rachael ValdezAvails Medical, Inc., Menlo Park, California, USA.
Nitin K RajanAvails Medical, Inc., Menlo Park, California, USA.
Meike S HergetAvails Medical, Inc., Menlo Park, California, USA.ORCID 0000-0002-5748-710X
Stefan RiedelDepartment of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.ORCID 0000-0002-0573-4957

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bloodstream infections frequently cause sepsis, a condition that can lead to organ dysfunction and death. Rapid antimicrobial susceptibility testing (AST) results are critical for appropriate medical intervention and to either de-escalate or escalate antibiotics to appropriate therapy. We describe the results from a multicenter clinical study evaluating the performance of the eQUANT system (Avails Medical, Inc., Menlo Park, CA). The eQUANT system generates a 0.5 McFarland equivalent suspension, the eMcFarland, directly from a positive blood culture bottle for use with downstream disk diffusion AST, thereby saving up to 24 hours compared to traditional AST workflow. A combination of fresh, prospectively collected clinical (42) and contrived (525) blood cultures were tested, and results for disk diffusion using the Avails eQUANT eMcFarland suspension as the inoculum were compared to disk diffusion results the next day using the standard 0.5 McFarland suspension prepared from plate subculture. Thirteen species of gram-negative rods were evaluated against 12 antibiotics. From the 2,679 pairs of AST results, overall categorical agreement was 95.0%. Overall very major errors, major errors, and minor errors were 0.15%, 0.60%, and 4.48%, respectively. The Avails eQUANT system has the potential to significantly accelerate the standard of care by eliminating the need for subculture.IMPORTANCERapid reporting of antimicrobial susceptibility test results for bacterial isolates from blood cultures is critical for timely implementation of optimal antimicrobial therapy and improves outcomes of sepsis patients. In this study, we demonstrate the accuracy and performance characteristics of the eQUANT system, which generates a 0.5 McFarland equivalent suspension, the eMcFarland, directly from a positive blood culture bottle for use with downstream disk diffusion antimicrobial susceptibility testing (AST). Using the eMcFarland suspension allows for accurate and standardized reporting of disk diffusion AST results from positive blood cultures.

Indexed as

Anti-Bacterial AgentsBacteremiaBlood CultureDisk Diffusion Antimicrobial TestsGram-Negative BacteriaGram-Negative Bacterial InfectionsFemaleHumansMaleProspective StudiesAnti-Bacterial Agentsantimicrobial susceptibility testingbloodstream infections (BSIs)disk diffusion testingeMcFarlandeQUANT systempositive blood cultures (PBCs)sepsisstandardized inoculum

Identifiers

PMID40340515
PMCPMC12153300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.